Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

'Get Him!': Watch as Brave Man Rescues Portion of American Flag Being Burned by 'Pro-Hamas Agitators' [Video]

A Growing Global Movement of Parents Is Keeping Their Kids Free from Smartphones

Democrat Downplays That Bill Would Cost Trump His Secret Service Detail

Teacher's Union Accused of Laundering $1.5 Million to Bankroll Dem Governor Josh Shapiro's Campaign

Dan Bongino: 9 Reasons to Vote for Kamala Harris

New Comms Director for Kamala Harris Campaign Wants to Pack the Supreme Court and Defund the Police

Pro-Life Protester Sentenced to More Than 3 Years Behind Bars for Blocking Abortion Clinic

Ben Carson Gives Perfect Defense of Pro-Life Position and Much More, in Powerful Tucker Carlson Interview [Watch]

Pastor Faced Death Threats, Had to Go into Hiding after Revealing Political Beliefs: 'I Reject the Victimhood Mentality'

'Hey Mom, I'm Trans!': The Truth About the Gender Dysphoria Deception, from a Mom in the Middle of It

These Important Election Integrity Initiatives Might Be on Your 2024 Ballot

Harris Campaign Admits to Misleading Voters on Trump, Project 2025

Pro-Harris Media Scrambles to Erase 'Border Czar' from Her Resume as GOP Highlights Her Record

House Republicans Raise American Flags at Union Station in DC after Chaotic Protesting Hamas Supporters Took Down and Burned Flags

Netanyahu Hails Israeli-US Bond, Reminds Protesters Israel the 'Land of the Bible' for 4,000 Years

'Influencing the Culture': Megachurch Equipping Churches to Mobilize Voters Ahead of November Election

Pray: Elderly Trump Supporter Run Over in Front Yard

Elon Musk Says AI Must Be 'Pro-Human,' Is Alarmed by Technological Developments

The Man and the Motive: Behind Musk's War on the 'Woke Mind Virus,' and Why He Fights for Children

Alberta Premier Danielle Smith Promises Bill Protecting Rights to Refuse Vaccines Is Coming